References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
Changing HIV treatment is a normal part of long-term care. People switch for many reasons — side effects, drug interactions, new options with fewer pills, or convenience. Modern ART offers many choices, and switching is usually straightforward when done properly with your HIV team.
Here’s what to know about when, why and how treatment changes happen.
Order a discreet home HIV test
Common Reasons for Switching
| Reason | Examples |
|---|---|
| Side effects | Weight gain, mood changes, nausea, diarrhoea, sleep problems |
| Drug interactions | New medication that conflicts with current ART |
| Simplification | Moving from multiple pills to a single tablet |
| Pregnancy | Switching to a pregnancy-safe regimen |
| Kidney or bone health | Moving from TDF to TAF |
| Long-acting option | Switching from daily pills to injections |
| Cost/availability | NHS formulary changes |
| Treatment failure | Rising viral load despite adherence |
How Switching Works
- Your HIV team discusses the reason for switching and the options
- Resistance testing may be done to confirm the new regimen will work
- Hepatitis B status is checked — some switches need careful planning
- You start the new regimen, usually the day after stopping the old one
- Viral load is checked 4-8 weeks after switching to confirm it’s working
What to Expect After Switching
- Mild adjustment symptoms are normal in the first few weeks
- Most people notice improvements in the side effects that prompted the switch
- Your viral load should remain undetectable
- If new side effects develop, they usually settle within 2-4 weeks
When NOT to Switch on Your Own
Never stop or change your HIV medication without discussing with your HIV team. Risks of unsupervised changes include:
- Viral load rebound
- Drug resistance
- Hepatitis B flare (if stopping tenofovir/emtricitabine/lamivudine)
- Losing U=U protection
Switching for Convenience
If your current treatment is working well but you’d like fewer pills or to stop taking tablets altogether, talk to your clinic about:
- Single-tablet regimens (Biktarvy, Dovato, Triumeq, Symtuza)
- Two-drug regimens if eligible
- Long-acting injectable treatment (cabotegravir/rilpivirine)
Read more: Side effects of HIV treatment | Single-tablet treatments | Injectable treatment
Frequently Asked Questions
If the switch is done properly with your HIV team, your viral load should remain undetectable. It’s checked a few weeks after switching to confirm.
Can I switch to reduce weight gain?
Possibly. Some people lose weight after switching from an integrase inhibitor to a different class. Your HIV team can discuss the trade-offs.
How often can I switch?
As often as needed, provided each switch is clinically appropriate and your viral load stays suppressed. Some people switch several times over the course of their treatment.
Related reading
- Injectable HIV Treatment: Everything You Need to Know
- Are HIV Tests Accurate If You're on PrEP, PEP or ART?
- CD4/CD8 Ratio: What It Means and Why It Matters
- CD4 Counts Explained: What Your Numbers Mean
- Efavirenz for HIV: An Older NNRTI Still in Use
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
